迈克生物(300463.SZ)：前三季净利润3710万元 同比下降86.81%

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the third quarter, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for the first three quarters was 1.6 billion, representing a year-on-year decrease of 17.44% [1] - The net profit attributable to shareholders for the same period was 37.1 million, down 86.81% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 64.3 million, reflecting a year-on-year decline of 77.95% [1]